CY1110467T1 - 2- (OTHER-) ARYLI SUBSTITUTED SUBSTITUTES OF tetrahydroquinoline - Google Patents

2- (OTHER-) ARYLI SUBSTITUTED SUBSTITUTES OF tetrahydroquinoline

Info

Publication number
CY1110467T1
CY1110467T1 CY20091100093T CY091100093T CY1110467T1 CY 1110467 T1 CY1110467 T1 CY 1110467T1 CY 20091100093 T CY20091100093 T CY 20091100093T CY 091100093 T CY091100093 T CY 091100093T CY 1110467 T1 CY1110467 T1 CY 1110467T1
Authority
CY
Cyprus
Prior art keywords
aryli
tetrahydroquinoline
substitutes
substituted
substituted substitutes
Prior art date
Application number
CY20091100093T
Other languages
Greek (el)
Inventor
Kai Schiemann
Ulrich Emde
Dirk Finsinger
Johannes Gleitz
Helmut Reubold
Frank Zenke
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10360154A external-priority patent/DE10360154A1/en
Priority claimed from DE102004026026A external-priority patent/DE102004026026A1/en
Priority claimed from EP04803833A external-priority patent/EP1761515B1/en
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of CY1110467T1 publication Critical patent/CY1110467T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

Οι ενώσεις του τύπου όπου τα W, R, R1, R2, R3, R4, R5, R6 και R7 έχουν τις σημασίες που αναφέρονται στην Αξίωση 1, μπορούν να χρησιμοποιηθούν μεταξύ άλλων για την αντιμετώπιση των όγκων.Compounds of the formula wherein W, R, R1, R2, R3, R4, R5, R6 and R7 have the meanings set forth in Claim 1, may be used inter alia to treat tumors.

CY20091100093T 2003-12-20 2009-01-27 2- (OTHER-) ARYLI SUBSTITUTED SUBSTITUTES OF tetrahydroquinoline CY1110467T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10360154A DE10360154A1 (en) 2003-12-20 2003-12-20 New 2-(hetero)aryl-tetrahydroquinoline derivatives and 1,2,3,4-tetrahydro-1,5-naphthyridine derivatives are mitotic motor protein Eg5 inhibitors used as anticancer agents for treating carcinoma or leukemia
US53996104P 2004-01-30 2004-01-30
DE102004026026A DE102004026026A1 (en) 2004-05-27 2004-05-27 New 2-(hetero)aryl-tetrahydroquinoline derivatives and 1,2,3,4-tetrahydro-1,5-naphthyridine derivatives are mitotic motor protein Eg5 inhibitors used as anticancer agents for treating carcinoma or leukemia
EP04803833A EP1761515B1 (en) 2003-12-20 2004-12-14 2-(hetero-)aryl substituted tetrahydroquinoline derivatives

Publications (1)

Publication Number Publication Date
CY1110467T1 true CY1110467T1 (en) 2015-04-29

Family

ID=34743228

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20091100093T CY1110467T1 (en) 2003-12-20 2009-01-27 2- (OTHER-) ARYLI SUBSTITUTED SUBSTITUTES OF tetrahydroquinoline
CY20111100701T CY1111704T1 (en) 2003-12-20 2011-07-19 TYPES OF PYRANO-KINOLIN TETHYDRATE

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY20111100701T CY1111704T1 (en) 2003-12-20 2011-07-19 TYPES OF PYRANO-KINOLIN TETHYDRATE

Country Status (6)

Country Link
KR (1) KR101211973B1 (en)
AR (1) AR047068A1 (en)
CY (2) CY1110467T1 (en)
DE (1) DE502004008434D1 (en)
HK (1) HK1096395A1 (en)
MX (1) MXPA06006714A (en)

Also Published As

Publication number Publication date
MXPA06006714A (en) 2006-08-18
KR20060127002A (en) 2006-12-11
DE502004008434D1 (en) 2008-12-18
AR047068A1 (en) 2006-01-04
KR101211973B1 (en) 2012-12-13
HK1096395A1 (en) 2007-06-01
CY1111704T1 (en) 2015-10-07

Similar Documents

Publication Publication Date Title
CY1118498T1 (en) PYRIDAZINONINE PRODUCERS
CY1112206T1 (en) PYRIDAZINONINE PRODUCTS FOR TREATMENT TREATMENT
DK1070056T3 (en) Phthalazinone PDE III / IV Inhibitors
CY1114554T1 (en) INDAZOLIA, FANZOTRIAZOLIA, AND N-analogues of these as p38 kinase inhibitors
DK0590428T3 (en) Azaquinoxalins, methods for their preparation and their use
ATE469892T1 (en) SUBSTITUTED 1H-DIHYDROPYRAZOLES, THEIR PREPARATION AND USE
CY1112780T1 (en) NEW SULFONYLPYRROLIA AS HDAC SUSPENSIONS
TR199901653T2 (en) Phthalazinones.
CY1112031T1 (en) Substituted 5-phenyl-3,6-dihydro-2-oxo-6H- [1,3,4] thiadiazine
EE200000033A (en) Novel tetrazole derivatives
EA200301100A1 (en) NEW PHTHALASINOSES
CY1111432T1 (en) Tetrahydroquinolines for use as modulators of the kinetic protein kinetic EG5
DE60121345D1 (en) ALKYLATED IMIDAZOPYRIDINE DERIVATIVES
ATE311389T1 (en) PRECURSOR OF IMIDAZOPYRIDINE DERIVATIVES
ATE302772T1 (en) 2-(1H-INDOL-3-YL)-2-OXO-ACETAMIDE WITH ANTI-TUMORAL EFFECT
DE60127131D1 (en) TRICYCLIC IMIDAZOPYRIDINE
SE0003476D0 (en) Compounds
ATE287403T1 (en) 6-PHENYLBENZONAPHTHYIDINE
SE9903290D0 (en) Novel compounds
ATE368649T1 (en) CYANOGUANIDINE PRODRUGS
DE60131968D1 (en) PYRANOE2,3-CIMIDAZOÄ1,2-ATPYRIDINE DERIVATIVES FOR THE TREATMENT OF GASTROINTESTINAL DISEASES
CY1110467T1 (en) 2- (OTHER-) ARYLI SUBSTITUTED SUBSTITUTES OF tetrahydroquinoline
CY1106472T1 (en) THE USE OF HYDROXYPYRIDONE DERIVATIVES IN WOUND HEALING
TR200100475T2 (en) Production and uses of N-substituted azabicycloheptane derivatives.
ATE374778T1 (en) ORGANOSILICON COMPOUNDS AND THEIR USE